Rachelle Kosoff

1.8k total citations
14 papers, 1.1k citations indexed

About

Rachelle Kosoff is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Rachelle Kosoff has authored 14 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Immunology and 4 papers in Oncology. Recurrent topics in Rachelle Kosoff's work include PI3K/AKT/mTOR signaling in cancer (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Rachelle Kosoff is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Rachelle Kosoff collaborates with scholars based in United States, Netherlands and Germany. Rachelle Kosoff's co-authors include Jonathan Chernoff, Maria Radu, Galina Semenova, Katherine B. Ragan, Justin P. Ingram, Siddharth Balachandran, Luis J. Sigal, Peter Vogel, Shoko Nogusa and Jason W. Upton and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Nature reviews. Cancer.

In The Last Decade

Rachelle Kosoff

14 papers receiving 1.1k citations

Peers

Rachelle Kosoff

IMMUN

ONCOL

Christine Wagner Austria

Kazuya Okada Japan

Catherine J. Huntoon United States

Emilio Lecona Spain

Paul M. Grandgenett United States

Katherine Oravecz-Wilson United States

Stephen Ma Australia

Xiaochun Wan China

Weicheng Wu China

J.J. Keusch Switzerland

Christine Wagner Austria

Rachelle Kosoff

497 ×0.7

391 ×1.2

IMMUN

392 ×1.5

ONCOL

96 ×0.7

111 ×1.0

Citations per year, relative to Rachelle Kosoff Rachelle Kosoff (= 1×) peers Christine Wagner

Countries citing papers authored by Rachelle Kosoff

Since Specialization

Citations

This map shows the geographic impact of Rachelle Kosoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachelle Kosoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachelle Kosoff more than expected).

Fields of papers citing papers by Rachelle Kosoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachelle Kosoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachelle Kosoff. The network helps show where Rachelle Kosoff may publish in the future.

Co-authorship network of co-authors of Rachelle Kosoff

This figure shows the co-authorship network connecting the top 25 collaborators of Rachelle Kosoff. A scholar is included among the top collaborators of Rachelle Kosoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachelle Kosoff. Rachelle Kosoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Muik, Alexander, Rachelle Kosoff, Friederike Gieseke, et al.. (2021). Abstract 1846: DuoBody-CD40×4-1BB (GEN1042) induces dendritic-cell maturation and enhances T-cell activation and effector functions in vitro by conditional CD40 and 4-1BB agonist activity. Cancer Research. 81(13_Supplement). 1846–1846. 2 indexed citations

Muik, Alexander, Işıl Altıntaş, Rachelle Kosoff, et al.. (2020). 561 DuoBody®-PD-L1×4–1BB (GEN1046) induces superior immune-cell activation, cytokine production and cytotoxicity by combining PD-L1 blockade with conditional 4–1BB co-stimulation. SHILAP Revista de lepidopterología. A338.2–A339. 2 indexed citations

Thapa, Roshan J., Justin P. Ingram, Katherine B. Ragan, et al.. (2016). DAI Senses Influenza A Virus Genomic RNA and Activates RIPK3-Dependent Cell Death. Cell Host & Microbe. 20(5). 674–681. 323 indexed citations

Kosoff, Rachelle, Joseph E. Aslan, John C. Kostyak, et al.. (2015). Pak2 restrains endomitosis during megakaryopoiesis and alters cytoskeleton organization. Blood. 125(19). 2995–3005. 39 indexed citations

Zeng, Yi, Hal E. Broxmeyer, Karl Staser, et al.. (2015). Pak2 Regulates Hematopoietic Progenitor Cell Proliferation, Survival, and Differentiation. Stem Cells. 33(5). 1630–1641. 21 indexed citations

Phee, Hyewon, Byron B. Au‐Yeung, Olga Pryshchep, et al.. (2014). Pak2 is required for actin cytoskeleton remodeling, TCR signaling, and normal thymocyte development and maturation. eLife. 3. e02270–e02270. 46 indexed citations

Dorrance, Adrienne M., Serena De Vita, Maria Radu, et al.. (2013). The Rac GTPase effector p21-activated kinase is essential for hematopoietic stem/progenitor cell migration and engraftment. Blood. 121(13). 2474–2482. 27 indexed citations

Radu, Maria, Galina Semenova, Rachelle Kosoff, & Jonathan Chernoff. (2013). PAK signalling during the development and progression of cancer. Nature reviews. Cancer. 14(1). 13–25. 374 indexed citations

Kosoff, Rachelle, Hoi Yee Chow, Maria Radu, & Jonathan Chernoff. (2012). Pak2 Kinase Restrains Mast Cell FcϵRI Receptor Signaling through Modulation of Rho Protein Guanine Nucleotide Exchange Factor (GEF) Activity. Journal of Biological Chemistry. 288(2). 974–983. 29 indexed citations

10.

Sela, Meirav, Dvora Beach, Thomas Oellerich, et al.. (2011). Sequential phosphorylation of SLP‐76 at tyrosine 173 is required for activation of T and mast cells. The EMBO Journal. 30(15). 3160–3172. 22 indexed citations

11.

Kosoff, Rachelle, et al.. (2011). Development and characterization of an organotypic model of Barrett's esophagus. Journal of Cellular Physiology. 227(6). 2654–2659. 29 indexed citations

12.

Merlo, Lauren M.F., et al.. (2011). An in vitro co-culture model of esophageal cells identifies ascorbic acid as a modulator of cell competition. BMC Cancer. 11(1). 461–461. 13 indexed citations

13.

Javvadi, Prashanthi, Lauren Hertan, Rachelle Kosoff, et al.. (2010). Thioredoxin Reductase-1 Mediates Curcumin-Induced Radiosensitization of Squamous Carcinoma Cells. Cancer Research. 70(5). 1941–1950. 89 indexed citations

14.

Arias‐Romero, Luis E., et al.. (2010). A Rac–Pak signaling pathway is essential for ErbB2-mediated transformation of human breast epithelial cancer cells. Oncogene. 29(43). 5839–5849. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact